Tunicamycin inhibits the differentiation of ST 13 fibroblasts to adipocytes with suppression of the insulin binding activity.
D000085:Acetates / Q000378:metabolism; D000273:Adipose Tissue / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000378:metabolism; D007328:Insulin / Q000378:metabolism*; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis*; D051379:Mice; D010743:Phospholipids / Q000096:biosynthesis; D014176:Protein Biosynthesis; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism*; D014280:Triglycerides / Q000096:biosynthesis; D014415:Tunicamycin / Q000494:pharmacology*
D000085:Acetates; D007328:Insulin; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D014415:Tunicamycin; D011972:Receptor, Insulin; D007930:Leucine; D005944:Glucosamine